NCT04313166
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Macquarie University Macquarie Park, New South Wales, Australia
Clinical trial condition
Neurodegenerative Diseases
Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.
9,046 public trials
1,772 recruiting studies
Neurodegenerative Diseases trial results
NCT01699451
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +9 more
- Locations
-
- Mayo Clinic Florida Jacksonville, Florida, United States
Completed
Risk Reduction for Alzheimer's Disease
NCT02913664
- Conditions
- Alzheimer Disease, Behavior, Brain Diseases, +14 more
- Locations
-
- University of Kansas Medical Center Research Institute Kansas City, Kansas, United States
- Pennington Biomedical Research Center Baton Rouge, Louisiana, United States
- Washington University in St. Louis St Louis, Missouri, United States
- UT Southwestern Medical Center Dallas, Texas, United States
NCT05237544
- Conditions
- Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +5 more
- Locations
-
- Dubowitz Neuromuscular Centre London, United Kingdom
NCT01954550
- Conditions
- Alzheimer Disease, Alzheimer's Disease, Late Onset, Behavior, +9 more
- Locations
-
- University of Minnesota Minneapolis, Minnesota, United States
NCT00486551
- Conditions
- ADHD, Aberrant Motor Behavior in Dementia, Aggression, +20 more
- Locations
-
- Yale University School of Medicine, Child Study Center New Haven, Connecticut, United States
NCT00362284
- Conditions
- Alzheimer Disease, Behavior, Behavioral Symptoms, +11 more
- Locations
-
- University of Minnesota, School of Nursing, 6-150 Weaver-Densford Hall Minneapolis, Minnesota, United States
- Silberstein Institute for Aging and Dementia, Department of Psychiatry, NYU School of Medicine New York, United States
NCT05201742
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
- Locations
-
- King Saud University Riyadh, Saudi Arabia
Completed
Open-label Extension Study of Pridopidine (ACR16) in the Symptomatic Treatment of Huntington Disease
NCT01306929
- Conditions
- Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
- Locations
-
Not specified
NCT02553265
- Conditions
- Autonomic Nervous System Diseases, Baroreflex Failure Syndrome, Cardiovascular Diseases, +15 more
- Locations
-
- NYU Langone Medical Center, Dyautonomia Center, Suite 9Q New York, United States
- NYU Medical Center New York, United States